Levomethadon

Levomethadone, the active ingredient in Levomethadon, is an opioid analgesic presented as a tablet for oral use. It is used to manage severe chronic pain and to support opioid substitution therapy in adults.

GNH USA supplies Levomethadon as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levomethadone is an opioid analgesic indicated for conditions that require strong pain control or opioid substitution.

Severe chronic pain: provides potent analgesia for patients with high‑intensity, long‑standing pain. Opioid dependence substitution therapy: reduces withdrawal symptoms and cravings in individuals with opioid use disorder. Cancer‑related pain: offers opioid analgesia for malignant disease‑associated pain.

Levomethadone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea and vomiting: gastrointestinal upset. - Drowsiness or sedation: central nervous system depression. - Dry mouth: reduced salivary flow. - Sweating: increased perspiration. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Respiratory depression: markedly reduced breathing effort. - Severe hypotension: dangerous drop in blood pressure. - Cardiac arrhythmias: abnormal heart rhythm. - Dependence or addiction: potential for misuse with prolonged use.

Levomethadone requires careful monitoring due to its opioid nature and potential for serious adverse events.

Assess respiratory function: monitor for signs of respiratory depression, especially after dose initiation or escalation. Evaluate liver function: adjust use in patients with hepatic impairment. Monitor for signs of dependence: watch for cravings, tolerance, or withdrawal. Avoid concomitant CNS depressants: limit use with benzodiazepines or alcohol. Adjust dose in renal impairment: consider reduced dosing in severe kidney disease. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levomethadone can interact with several drug classes, affecting safety and efficacy.

Major Interactions (Avoid): - MAO inhibitors: risk of severe serotonin syndrome. - Other central nervous system depressants (e.g., benzodiazepines, barbiturates): additive respiratory depression. - CYP3A4 strong inhibitors (e.g., ketoconazole, clarithromycin): increased levomethadone plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): reduced efficacy. - Serotonergic agents (e.g., SSRIs, SNRIs): potential for serotonin syndrome. - Antihistamines and anticholinergics: may enhance sedation and anticholinergic effects.